The Evidence for Twice-Daily Hydrocortisone Dosing in Children with Congenital Adrenal Hyperplasia Is Lacking
Horm Res Paediatr
.
2022;95(5):499-504.
doi: 10.1159/000525990.
Epub 2022 Jul 11.
Authors
Kyriakie Sarafoglou
1
2
,
Oppong Yaw Addo
3
,
James S Hodges
4
,
Richard C Brundage
2
,
Stafford L Lightman
5
,
Peter C Hindmarsh
6
,
Bradley S Miller
1
Affiliations
1
Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
2
Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, Minnesota, USA.
3
Department of Global Health, Rollins School of Emory University, Atlanta, Georgia, USA.
4
Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, Minnesota, USA.
5
Laboratories of Integrative Neuroscience and Endocrinology, School of Clinical Sciences, University of Bristol, Bristol, UK.
6
Departments of Paediatrics, University College London Hospitals, London, UK.
PMID:
35817014
DOI:
10.1159/000525990
No abstract available
Publication types
Letter
Comment
MeSH terms
Adrenal Hyperplasia, Congenital* / drug therapy
Child
Humans
Hydrocortisone
Substances
Hydrocortisone